相关实验视频

Updated: Jul 12, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

通过准选择性蛋白质降解来对抗癌症

María Del Mar Noblejas-López^1,2, David Tébar-García^1,2, Raquel López-Rosa^1,2

¹Centro Regional de Investigaciones Biomédicas (CRIB), Campus de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.

|October 28, 2023

概括

针对性蛋白质降解通过降解疾病蛋白质提供了新的癌症疗法. 像PROTACs和LYTACs这样的技术正在推动实验性治疗向临床应用发展.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

向蛋白质降解是癌症治疗的一个新的治疗策略.
降解剂药物通过促进蛋白质清除,比传统的抑制剂具有优势.
这些药物可以被设计成穿越细胞膜并增强降解通路.

研究的目的:

审查针对蛋白质降解技术的当前趋势.
突出TAC技术在临床应用方面的进展.
讨论各种TAC技术,包括PROTAC,PHOTAC,CLIPTAC,AUTAC,ATTEC,LYTAC和DUBTAC等. 这是一个非常好的机会.

主要方法:

针对性蛋白质降解策略的文献综述.
分析技术及其作用机制.
检查实验开发和临床进展.

主要成果:

这些技术展示了针对蛋白质降解的多种策略.
它们中的PROTAC,PHOTAC,CLIPTAC,AUTAC,ATTEC,LYTAC和DUBTAC是其中的关键进步.
这些技术显示出癌症治疗的巨大潜力.

结论:

有针对性的蛋白质降解代表了癌症治疗的前沿.
经过审查的TAC 技术正在从实验阶段迅速发展到潜在的临床应用.
这些创新方法的进一步开发可能会彻底改变癌症治疗.

关键词:

这就是ATTEC的做法.在AUTAC中使用AUTAC.这就是CLIPTAC.在 DUBTAC 里面,在LYTAC中,我们可以使用LYTAC 这是PHOTAC的照片.这就是PROTAC.纳米医药是一种纳米医药.精准医学是一门精准医学.蛋白质降解剂是一种蛋白质降解剂.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...